Cargando…

Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light

Bacterial antibiotic resistance is an alarming global issue that requires alternative antimicrobial methods to which there is no resistance. Antimicrobial photodynamic therapy (APDT) is a well-known method to combat this problem for many pathogens, especially Gram-positive bacteria and fungi. Hyperi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Seemi Tasnim, Le, Tram Anh Ngoc, Park, Jin-Soo, Kwon, Hak Cheol, Kang, Kyungsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956302/
https://www.ncbi.nlm.nih.gov/pubmed/31805742
http://dx.doi.org/10.3390/pharmaceutics11120641
_version_ 1783487127853465600
author Alam, Seemi Tasnim
Le, Tram Anh Ngoc
Park, Jin-Soo
Kwon, Hak Cheol
Kang, Kyungsu
author_facet Alam, Seemi Tasnim
Le, Tram Anh Ngoc
Park, Jin-Soo
Kwon, Hak Cheol
Kang, Kyungsu
author_sort Alam, Seemi Tasnim
collection PubMed
description Bacterial antibiotic resistance is an alarming global issue that requires alternative antimicrobial methods to which there is no resistance. Antimicrobial photodynamic therapy (APDT) is a well-known method to combat this problem for many pathogens, especially Gram-positive bacteria and fungi. Hypericin and orange light APDT efficiently kill Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and the yeast Candida albicans. Although Gram-positive bacteria and many fungi are readily killed with APDT, Gram-negative bacteria are difficult to kill due to their different cell wall structures. Pseudomonas aeruginosa is one of the most important opportunistic, life-threatening Gram-negative pathogens. However, it cannot be killed successfully by hypericin and orange light APDT. P. aeruginosa is ampicillin resistant, but we hypothesized that ampicillin could still damage the cell wall, which can promote photosensitizer uptake into Gram-negative cells. Using hypericin and ampicillin cotreatment followed by orange light, a significant reduction (3.4 log) in P. aeruginosa PAO1 was achieved. P. aeruginosa PAO1 inactivation and gut permeability improvement by APDT were successfully shown in a Caenorhabditis elegans model.
format Online
Article
Text
id pubmed-6956302
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69563022020-01-23 Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light Alam, Seemi Tasnim Le, Tram Anh Ngoc Park, Jin-Soo Kwon, Hak Cheol Kang, Kyungsu Pharmaceutics Article Bacterial antibiotic resistance is an alarming global issue that requires alternative antimicrobial methods to which there is no resistance. Antimicrobial photodynamic therapy (APDT) is a well-known method to combat this problem for many pathogens, especially Gram-positive bacteria and fungi. Hypericin and orange light APDT efficiently kill Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and the yeast Candida albicans. Although Gram-positive bacteria and many fungi are readily killed with APDT, Gram-negative bacteria are difficult to kill due to their different cell wall structures. Pseudomonas aeruginosa is one of the most important opportunistic, life-threatening Gram-negative pathogens. However, it cannot be killed successfully by hypericin and orange light APDT. P. aeruginosa is ampicillin resistant, but we hypothesized that ampicillin could still damage the cell wall, which can promote photosensitizer uptake into Gram-negative cells. Using hypericin and ampicillin cotreatment followed by orange light, a significant reduction (3.4 log) in P. aeruginosa PAO1 was achieved. P. aeruginosa PAO1 inactivation and gut permeability improvement by APDT were successfully shown in a Caenorhabditis elegans model. MDPI 2019-12-01 /pmc/articles/PMC6956302/ /pubmed/31805742 http://dx.doi.org/10.3390/pharmaceutics11120641 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alam, Seemi Tasnim
Le, Tram Anh Ngoc
Park, Jin-Soo
Kwon, Hak Cheol
Kang, Kyungsu
Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title_full Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title_fullStr Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title_full_unstemmed Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title_short Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light
title_sort antimicrobial biophotonic treatment of ampicillin-resistant pseudomonas aeruginosa with hypericin and ampicillin cotreatment followed by orange light
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956302/
https://www.ncbi.nlm.nih.gov/pubmed/31805742
http://dx.doi.org/10.3390/pharmaceutics11120641
work_keys_str_mv AT alamseemitasnim antimicrobialbiophotonictreatmentofampicillinresistantpseudomonasaeruginosawithhypericinandampicillincotreatmentfollowedbyorangelight
AT letramanhngoc antimicrobialbiophotonictreatmentofampicillinresistantpseudomonasaeruginosawithhypericinandampicillincotreatmentfollowedbyorangelight
AT parkjinsoo antimicrobialbiophotonictreatmentofampicillinresistantpseudomonasaeruginosawithhypericinandampicillincotreatmentfollowedbyorangelight
AT kwonhakcheol antimicrobialbiophotonictreatmentofampicillinresistantpseudomonasaeruginosawithhypericinandampicillincotreatmentfollowedbyorangelight
AT kangkyungsu antimicrobialbiophotonictreatmentofampicillinresistantpseudomonasaeruginosawithhypericinandampicillincotreatmentfollowedbyorangelight